Celltrion Healthcare, Studio Dragon blocks fetch $388m
The controlling shareholder of South Korean entertainment company Studio Dragon raised W166.1bn ($136.2m) this week after selling a portion of its stake.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: